www.bloomberg.com
Merck & Co. plans to pursue major acquisitions, citing an opportunity for “multi tens of billion” dollar deals. The pharmaceutical giant is actively seeking to expand its portfolio through large-scale transactions. This strategy aims to bolster its pipeline and offset potential revenue loss from expiring patents. Merck’s aggressive M&A approach signals its commitment to maintaining a dominant position in the competitive pharmaceutical industry.
Read More
